Oxford Parkinson's Disease Centre (OPDC) is a unique multidisciplinary research centre @ox.ac.uk established in 2010.
@OxfordPDCentre
Loading...
Oxford Parkinson’s Disease Centre collaborators announced as Group Leaders for new Parkinson’s Research Centre www.dpag.ox.ac.uk/opdc/oxford-...
Last month we celebrated the official launch of our Parkinson’s Research Centre, in partnership with @parkinsons.org.uk 🎉
đź“ą Watch the video below to hear Centre Director Prof Miratul Muqit outline his vision for the new centre.
ukdri.ac.uk/news-and-eve...
In a new #preprint, CRN Team Cragg discovers that dopamine and acetylcholine interactions in the striatum are spatially organized, with a hotspot in the anterior dorsolateral striatum linked to learning and movement-related behaviors.
đź”— Read the full preprint: bit.ly/4usoP8W
How do you get from a Parkinson's risk variant to an actual drug target? Dr Sophie Farrow's DEMON Network webinar uses chromatin interactions to map genetic risk to genes, cell type by cell type. Recording now up:
www.dementiaresearcher.nihr.ac.uk/demon-webina...
A warm welcome to Syrago Spanou, a Postdoc @oxforddpag.bsky.social based @kavlioxford.bsky.social Her research focuses on testing novel β-glucocerebrosidase (GCase) activators for the treatment of #Parkinson’s disease using mouse models & primary neuronal cultures. www.dpag.ox.ac.uk/team/syrago-...
đź“Ł We are seeking to appoint an experienced Head of Laboratory Operations. It is a key position in ensuring the efficient, compliant, and safe operation of the lab. Closing date: 23rd June 2026 at 12noon. bit.ly/3S0mEfj @kavlioxford.bsky.social @dpagathenaswan.bsky.social @oxforddpag.bsky.social
Video
Congratulations to Oxford Parkinson’s Disease Centre (OPDC) investigators, Professor Peter Magill, Professor of Neurobiology, Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences...
Dr Sophie Farrow's DEMON Network talk on using chromatin interactions to find cell-specific drug targets in Parkinson's disease. Watch the full session now.
📢New vacancy (3/3): Project Manager in Prof Andrew Sharott’s group, Nuffield Dept. of Clinical Neurosciences, University of Oxford.
⏳Deadline: 29 May 2026, 12pm BST.
www.bndu.ox.ac.uk/vacancies/pr...
@ndcnoxford.bsky.social @medsci.ox.ac.uk @ox.ac.uk
Why are some dopamine neurons more vulnerable in #Parkinsons?
Discovery Fellows Sayan Dutta, Janko Kajtez, Christiana Kontaxi, Mukesh Kumar, Matthew McGregor, and Kathryn Todd are studying how circuit function, metabolism, and synaptic signaling drive selective vulnerability ⬇️
đź”— bit.ly/4eW6BbU
📢New vacancy (1/3): Postdoctoral Neuroscientist (Sleep-Related Neural Dynamics) in Prof Andrew Sharott’s group, Nuffield Dept. of Clinical Neurosciences, University of Oxford.
⏳Deadline: 29 May 2026, 12pm BST.
www.bndu.ox.ac.uk/vacancies/po...
@ndcnoxford.bsky.social @medsci.ox.ac.uk @ox.ac.uk
UK Dementia Research Institute
New research reports evidence of reduced neurosupport in both control & GBA-N370S iPSC-derived midbrain astrocytes exposed to inflammatory cytokines, suggesting a role for reactive astrocytes in #Parkinsons pathology
www.nature.com/articles/s41...
